Presentation is loading. Please wait.

Presentation is loading. Please wait.

E-cadherin expression associated with differentiation and prognosis in patients with non–small cell lung cancer  Dage Liu, MD, Cheng-long Huang, MD, Kotaro.

Published byCordelia Horn Modified over 6 years ago

Similar presentations

Presentation on theme: "E-cadherin expression associated with differentiation and prognosis in patients with non–small cell lung cancer  Dage Liu, MD, Cheng-long Huang, MD, Kotaro."— Presentation transcript:

1 E-cadherin expression associated with differentiation and prognosis in patients with non–small cell lung cancer  Dage Liu, MD, Cheng-long Huang, MD, Kotaro Kameyama, MD, Eiichi Hayashi, MD, Akira Yamauchi, MD, Shoji Kobayashi, MD, Hiroyasu Yokomise, MD  The Annals of Thoracic Surgery  Volume 71, Issue 3, Pages (March 2001) DOI: /S (00)

2 Fig 1 Immunohistochemical staining of human non–small cell lung cancer tissues using the avidin-biotin-peroxidase complex procedure (original magnification, ×100). (A) An adenocarcinoma with positive membranous staining for E-cadherin (E-cadherin-positive). (B) A squamous cell carcinoma with positive membranous staining for E-cadherin (E-cadherin-positive). (C) An adenocarcinoma with heterogeneous cytoplasmic staining for E-cadherin (E-cadherin-reduced). (D) A squamous cell carcinoma with heterogeneous cytoplasmic staining for E-cadherin (E-cadherin-reduced). (E) An adenocarcinoma with negative E-cadherin expression. (F) A squamous cell carcinoma with negative E-cadherin expression. The Annals of Thoracic Surgery  , DOI: ( /S (00) )

3 Fig 2 Overall survival of 109 patients with non–small cell lung cancer in relation to their E-cadherin status. The Annals of Thoracic Surgery  , DOI: ( /S (00) )

Download ppt "E-cadherin expression associated with differentiation and prognosis in patients with non–small cell lung cancer  Dage Liu, MD, Cheng-long Huang, MD, Kotaro."

Similar presentations

Pathologic N1 non-small cell lung cancer: Correlation between pattern of lymphatic spread and prognosis Alessandro Marra, MD, PhD, Ludger Hillejan, MD,

Pathologic N1 non-small cell lung cancer: Correlation between pattern of lymphatic spread and prognosis Alessandro Marra, MD, PhD, Ludger Hillejan, MD,
Vascular endothelial growth factor expression in non-small-cell lung cancer: Prognostic significance in squamous cell carcinoma  Hideyuki Imoto, MD, Toshihiro.

Vascular endothelial growth factor expression in non-small-cell lung cancer: Prognostic significance in squamous cell carcinoma  Hideyuki Imoto, MD, Toshihiro.
Non–Small Cell Lung Cancer at the Extremes of Age: Impact on Diagnosis and Treatment  William C Nugent, MD, Mark T Edney, BA, Paul G Hammerness, BA, Bradley.

Non–Small Cell Lung Cancer at the Extremes of Age: Impact on Diagnosis and Treatment  William C Nugent, MD, Mark T Edney, BA, Paul G Hammerness, BA, Bradley.
Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L

Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L
Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes  Meng S. Shao, MD, Andrew T. Wong, MD,

Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes  Meng S. Shao, MD, Andrew T. Wong, MD,
High Expression of PHGDH Predicts Poor Prognosis in Non–Small Cell Lung Cancer  Jinhong Zhu, Jianqun Ma, Xudong Wang, Tianjiao Ma, Shu Zhang, Wei Wang,

High Expression of PHGDH Predicts Poor Prognosis in Non–Small Cell Lung Cancer  Jinhong Zhu, Jianqun Ma, Xudong Wang, Tianjiao Ma, Shu Zhang, Wei Wang,
Rodrigo A. S. Sardenberg, MD, Clovis Pinto, MD, Cynthia A

Rodrigo A. S. Sardenberg, MD, Clovis Pinto, MD, Cynthia A
Malignant minor pleural effusion detected on thoracotomy for patients with non–small cell lung cancer: is tumor resection beneficial for prognosis?  Noriyoshi.

Malignant minor pleural effusion detected on thoracotomy for patients with non–small cell lung cancer: is tumor resection beneficial for prognosis?  Noriyoshi.
A Novel Classification of MUC1 Expression Is Correlated with Tumor Differentiation and Postoperative Prognosis in Non–Small Cell Lung Cancer  Shinjiro.

A Novel Classification of MUC1 Expression Is Correlated with Tumor Differentiation and Postoperative Prognosis in Non–Small Cell Lung Cancer  Shinjiro.
Collision Tumor of Esophagus: Report of Three Cases

Collision Tumor of Esophagus: Report of Three Cases
Clinicopathological and biological assessment of lung cancers with pleural dissemination  Yasuhiko Ohta, MD, Yoko Tanaka, PhD, Takuo Hara, MD, Makoto.

Clinicopathological and biological assessment of lung cancers with pleural dissemination  Yasuhiko Ohta, MD, Yoko Tanaka, PhD, Takuo Hara, MD, Makoto.
Prognostic Significance of TAZ Expression in Resected Non-Small Cell Lung Cancer  Mian Xie, MD, PhD, Li Zhang, MD, Chao-Sheng He, MD, Jin-Hui Hou, MD,

Prognostic Significance of TAZ Expression in Resected Non-Small Cell Lung Cancer  Mian Xie, MD, PhD, Li Zhang, MD, Chao-Sheng He, MD, Jin-Hui Hou, MD,
Significance of P53 and Rb protein expression in surgically treated non-small cell lung cancers  Yung-Chie Lee, MD, PhD, Yih-Leong Chang, MD, Shi-Ping.

Significance of P53 and Rb protein expression in surgically treated non-small cell lung cancers  Yung-Chie Lee, MD, PhD, Yih-Leong Chang, MD, Shi-Ping.
APLCC ORAL ABSTRACT SESSIONS - MONDAY, NOVEMBER 26

APLCC ORAL ABSTRACT SESSIONS - MONDAY, NOVEMBER 26
Surgical Results and Prognostic Factors in Early Non–Small Cell Lung Cancer  José Padilla, MD, Vı́ctor Calvo, MD, Juan C Peñalver, MD, Gabriel Sales, MD,

Surgical Results and Prognostic Factors in Early Non–Small Cell Lung Cancer  José Padilla, MD, Vı́ctor Calvo, MD, Juan C Peñalver, MD, Gabriel Sales, MD,
Prognostic significance of neuroendocrine differentiation in adenocarcinoma of the lung  Kenzo Hiroshima, MD, Akira Iyoda, MD, Kiyoshi Shibuya, MD, Tetsuya.

Prognostic significance of neuroendocrine differentiation in adenocarcinoma of the lung  Kenzo Hiroshima, MD, Akira Iyoda, MD, Kiyoshi Shibuya, MD, Tetsuya.
Putative Stem Cell Markers in Non–Small-Cell Lung Cancer: A Clinicopathologic Characterization  Willam Sterlacci, MD, Spasenija Savic, MD, Michael Fiegl,

Putative Stem Cell Markers in Non–Small-Cell Lung Cancer: A Clinicopathologic Characterization  Willam Sterlacci, MD, Spasenija Savic, MD, Michael Fiegl,
Epidermal Growth Factor Receptor Is a Prognosis Predictor in Patients With Esophageal Squamous Cell Carcinoma  Wencheng Zhang, MD, Hongxia Zhu, MD, Xiao.

Epidermal Growth Factor Receptor Is a Prognosis Predictor in Patients With Esophageal Squamous Cell Carcinoma  Wencheng Zhang, MD, Hongxia Zhu, MD, Xiao.
Osteopontin Combined With CD44v6, a Novel Prognostic Biomarker in Non-Small Cell Lung Cancer Undergoing Curative Resection  Bing-sheng Sun, MD, PhD, Yue.

Osteopontin Combined With CD44v6, a Novel Prognostic Biomarker in Non-Small Cell Lung Cancer Undergoing Curative Resection  Bing-sheng Sun, MD, PhD, Yue.
Tumor Angiogenesis as a Prognostic Marker in Operable Non–Small Cell Lung Cancer  Katsuhiko Matsuyama, Yukio Chiba, Masato Sasaki, Hirokazu Tanaka, Ryusuke.

Tumor Angiogenesis as a Prognostic Marker in Operable Non–Small Cell Lung Cancer  Katsuhiko Matsuyama, Yukio Chiba, Masato Sasaki, Hirokazu Tanaka, Ryusuke.

Similar presentations

Ads by Google